Supplement tax bill
"Dietary Supplement Tax Fairness Act" introduced in Senate Aug. 2 would make cost of dietary supplements, medical foods and foods for special dietary use tax-deductible for employers, excluded from taxable income for employees, Sen. Tom Harkin (D-Iowa) explained in same-day comments. Harkin cosponsored S 1330 with Sen. Orrin Hatch (R-Utah). Bill would allow such products to be treated as medical expenses, even though they are not drugs. However, measure would require supplements meet GMP standards "to receive the improved tax treatment," Harkin notes. Bill has been assigned to Finance Committee
More from Archive
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
More from Pink Sheet
All RSV vaccines with US FDA approval for high-risk younger adult patients will be incorporated in US CDC’s Advisory Committee for Immunization Practices recommendations. Merck’s infant RSV antibody is on track for a June vote
Wide-ranging executive order to lower drug prices also hints at changes in upcoming guidance on the Medicare price negotiation program but few other potentially impactful near-term actions.
Eisai is working on securing reimbursement across the EU for Leqembi now that the Alzheimer’s disease treatment has secured marketing approval from the European Commission.